공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 OTC 의약품 시장 : 제품(기침, 감기&인플루엔자, 진통제, 피부과 제품, 비타민, 미네랄, 보충제), 제형, 유통채널, 지역별 예측, 기회(-2025년)

Global Over the Counter Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements, Other), By Dosage Form, By Distribution Channel, By Region, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2021년 01월 상품 코드 979721
페이지 정보 영문 112 Pages
가격
US $ 4,450 ₩ 4,953,000 Unprintable PDF and Excel (Single User License)
US $ 5,450 ₩ 6,066,000 PDF and Excel (Multi-User License)
US $ 9,450 ₩ 10,518,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



세계의 OTC 의약품 시장 : 제품(기침, 감기&인플루엔자, 진통제, 피부과 제품, 비타민, 미네랄, 보충제), 제형, 유통채널, 지역별 예측, 기회(-2025년) Global Over the Counter Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements, Other), By Dosage Form, By Distribution Channel, By Region, Forecast & Opportunities, 2025
발행일 : 2021년 01월 페이지 정보 : 영문 112 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 OTC 의약품 시장 규모는 2019년 1,400억 달러를 웃돌았고, 예측기간 중 약 8.23%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측됩니다. 세계 OTC 의약품 시장은 전 세계 사람들의 건강의식 고양에 의해 성장이 가속되고 있습니다. OTC 의약품 구입은 처방전을 필요로 하지 않기 때문에 비용 효과가 높고, 예측기간 중 시장 성장에 긍정적인 영향을 미칠 것으로 예상됩니다. OTC 의약품의 가용성과 적정한 가격은 시장에서의 OTC 의약품 채용률을 더욱 높이고 있습니다. 또 급속하게 확대되는 헬스케어 및 의약품 업계는 향후 몇 년간 시장 성장을 더 가속할 것으로 예측됩니다.

세계의 OTC 의약품(Over the Counter Drugs) 시장에 대해 조사했으며, 부문별 분석과 예측, 시장 동향 및 경쟁 구도 분석, 주요 기업 프로파일 등의 정보를 정리하여 전해드립니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 COVID-19가 세계 OTC 의약품 시장에 미치는 영향

제4장 개요

제5장 고객의 견해

제6장 세계의 OTC 의약품 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별(기침, 감기&인플루엔자, 진통제, 피부과 제품, 비타민, 미네랄, 보충제(VMS), 기타)
    • 제형별(정제, 캡슐, 분말, 연고, 액체)
    • 유통채널별(병원 약국, 소매 약국, 온라인 약국, 기타)
    • 기업별
    • 지역별
  • 제품 시장 맵

제7장 아시아태평양의 OTC 의약품 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별
    • 제형별
    • 유통채널별
    • 국가별
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 호주
    • 일본
    • 한국

제8장 유럽의 OTC 의약품 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별
    • 제형별
    • 유통채널별
    • 국가별
  • 유럽 : 국가별 분석
    • 프랑스
    • 독일
    • 영국
    • 이탈리아
    • 스페인

제9장 북미의 OTC 의약품 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별
    • 제형별
    • 유통채널별
    • 국가별
  • 북미 : 국가별 분석
    • 미국
    • 멕시코
    • 캐나다

제10장 남미의 OTC 의약품 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별
    • 제형별
    • 유통채널별
    • 국가별
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제11장 중동 및 아프리카의 OTC 의약품 시장 전망

  • 시장 규모와 예측
    • 금액 기준
  • 시장 점유율과 예측
    • 제품별
    • 제형별
    • 유통채널별
    • 국가별
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제12장 시장 역학

  • 촉진요인
  • 과제

제13장 시장 동향

제14장 경쟁 구도

  • 경쟁 전망
  • 기업 개요
  • 주요 기업 개요
    • Johnson and Johnson
    • GlaxoSmithKline PLC(GSK Consumer Healthcare)
    • Perrigo Company PLC
    • Reckitt Benckiser Group PLC
    • Takeda Pharmaceutical Company Ltd
    • Roche Holding AG
    • The Procter & Gamble Company
    • Sanofi S.A
    • Gilead Sciences Inc.
    • Bayer Healthcare AG
    • AstraZeneca plc.
    • Alacer Corp.
    • Alcon Inc.

제15장 전략적 추천사항

제16장 당사에 대해&면책사항

LSH 21.01.12

List of Figures

  • Figure 1: Global OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 2: Global OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 3: Global OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 4: Global OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 5: Global OTC Drugs Market Size, By Company (USD Million), 2015-2025F
  • Figure 6: Global OTC Drugs Market Size, By Region (USD Million), 2015-2025F
  • Figure 7: Global OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 8: North America OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 9: North America OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 10: North America OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 11: North America OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 12: North America OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 13: North America OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 14: North America OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 15: United States OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 16: United States OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 17: United States OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 18: United States OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 19: United States OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 20: Canada OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 21: Canada OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 22: Canada OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 23: Canada OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 24: Canada OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 25: Mexico OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 26: Mexico OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 27: Mexico OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 28: Mexico OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 29: Mexico OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 30: Europe OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 31: Europe OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 32: Europe OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 33: Europe OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 34: Europe OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 35: Europe OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 36: Europe OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 37: France OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 38: France OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 39: France OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 40: France OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 41: France OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 42: Germany OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 43: Germany OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 44: Germany OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 45: Germany OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 46: Germany OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 47: Italy OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 48: Italy OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 49: Italy OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 50: Italy OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 51: Italy OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 52: Spain OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 53: Spain OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 54: Spain OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 55: Spain OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 56: Spain OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 57: United Kingdom OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 58: United Kingdom OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 59: United Kingdom OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 60: United Kingdom OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 61: United Kingdom OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 62: Asia-Pacific OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 63: Asia-Pacific OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 64: Asia-Pacific OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 65: Asia-Pacific OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 66: Asia-Pacific OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 67: Asia-Pacific OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 68: Asia-Pacific OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 69: China OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 70: China OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 71: China OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 72: China OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 73: China OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 74: India OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 75: India OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 76: India OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 77: India OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 78: India OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 79: Japan OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 80: Japan OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 81: Japan OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 82: Japan OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 83: Japan OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 84: South Korea OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 85: South Korea OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 86: South Korea OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 87: South Korea OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 88: South Korea OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 89: Australia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 90: Australia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 91: Australia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 92: Australia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 93: Australia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 94: Middle East and Africa OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 95: Middle East and Africa OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 96: Middle East and Africa OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 97: Middle East and Africa OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 98: Middle East and Africa OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 99: Middle East and Africa OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 100: Middle East and Africa OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 101: South Africa OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 102: South Africa OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 103: South Africa OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 104: South Africa OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 105: South Africa OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 106: Saudi Arabia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 107: Saudi Arabia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 108: Saudi Arabia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 109: Saudi Arabia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 110: Saudi Arabia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 111: Kuwait OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 112: Kuwait OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 113: Kuwait OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 114: Kuwait OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 115: Kuwait OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 116: UAE OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 117: UAE OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 118: UAE OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 119: UAE OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 120: UAE OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 121: South America OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 122: South America OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 123: South America OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 124: South America OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 125: South America OTC Drugs Market Size, By Country (USD Million), 2015-2025F
  • Figure 126: South America OTC Drugs Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 127: South America OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 128: Brazil OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 129: Brazil OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 130: Brazil OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 131: Brazil OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 132: Brazil OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 133: Argentina OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 134: Argentina OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 135: Argentina OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 136: Argentina OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 137: Argentina OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F
  • Figure 138: Colombia OTC Drugs Market Size, By Value (USD Million), 2015-2025F
  • Figure 139: Colombia OTC Drugs Market Size, By Product (USD Million), 2015-2025F
  • Figure 140: Colombia OTC Drugs Market Size, By Dosage Form (USD Million), 2015-2025F
  • Figure 141: Colombia OTC Drugs Market Size, By Distribution Channel (USD Million), 2015-2025F
  • Figure 142: Colombia OTC Drugs Market Size Attractiveness Index, By Product, By Value, 2015-2025F

Title:
Global Over the Counter (OTC) Drugs Market, By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other), By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other), By Region, Forecast & Opportunities, 2025.

Global Over the Counter (OTC) drugs market exceeded USD 140 billion in 2019 and is expected to grow at a CAGR of around 8.23% during the forecast period. The global OTC drugs market is driven by rising health consciousness among the population across the globe. Moreover, buying OTC drugs is cost effective as they need no prescription, which is expected to positively impact the growth of market during the forecast period. The availability and affordability of these medicines has further increased the adoption rates of the OTC drugs in the market. Also, rapidly expanding healthcare and pharmaceuticals industries, is further expected to bolster the growth of market over the next few years.

The global over the counter (OTC) drugs market is segmented based on product, dosage form, distribution channel, company, and region. Based on product, the market can be categorized into cough, cold and flu products, analgesics, dermatology products, vitamins, mineral and supplements (VMS) and other. Out of these, the cough, cold, and flu products segment dominated the market in terms of largest market share until 2019 and is expected to maintain its leading position the market during the forecast period as well. This can be ascribed to growing number of infections which is leading to the rise in the number of infectious diseases. The market is further driven by the increasing efforts to licencing of OTC drugs for the treatment of cough, cold and flu. In addition to this, vitamins, mineral, and supplements (VMS) segment is expected to grow at a high pace in the next 5 years on account of the rising popularity of VMS products in developed countries because of the increasing diseased population. Based on the dosage form, the market is segmented into tablets, capsules, ointments, liquids, and powders. Out of these, tablets segment dominates the market and is expected to maintain its position. Tablets are usually preferred by the doctors and patients as it is the most convenient oral dosage form. Based on the distribution channel, the market can be segmented into retail pharmacies, hospital pharmacies, online pharmacy, and others. Out of these, retail pharmacies segment is the leading segment as, these are easily accessible. Furthermore, retail pharmacies have availability of a variety of drugs.

Major players operating in the global over the counter (OTC) drugs market include Johnson and Johnson, GlaxoSmithKline PLC (GSK Consumer Healthcare), Perrigo Company PLC, Reckitt Benckiser Group PLC, Takeda Pharmaceutical Company Ltd, Roche Holding AG, The Procter & Gamble Company, Sanofi S.A, Gilead Sciences Inc., Bayer Healthcare AG, AstraZeneca plc., Alacer Corp., Alcon Inc., and others. The companies are developing advanced technologies and launching new products to stay competitive in the market. Other competitive strategies include mergers & acquisitions, partnership, agreements, and new developments in order to expand their geographic reach and to increase their customer bases.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and estimate the market size of global over the counter (OTC) drugs market from 2015 to 2018.
  • To estimate and forecast the market size of global over the counter (OTC) drugs market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global over the counter (OTC) drugs market based on product, dosage form, distribution channel, company and regional distribution.
  • To identify dominant region or segment in the global over the counter (OTC) drugs market.
  • To identify drivers and challenges for global over the counter (OTC) drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global over the counter (OTC) drugs market.
  • To conduct pricing analysis for global over the counter (OTC) drugs market.
  • To identify and analyze the profile of leading players operating in global over the counter (OTC) drugs market.
  • To identify key sustainable strategies adopted by market players in global over the counter (OTC) drugs market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the products and presence of all major players across the globe.

TechSci Research calculated the market size of global over the counter (OTC) drugs market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these services and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Over the counter (OTC) drugs manufacturers, suppliers and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to over the counter (OTC) drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global over the counter (OTC) drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Over the Counter (OTC) Drugs Market, By Product:

Cough, Cold, and Flu, Analgesics

Dermatology Products

Vitamins, Mineral, and Supplements (VMS)

Other

  • Global Over the Counter (OTC) Drugs Market, By Dosage Form:

Tablets

Capsules

Powders

Ointments

Liquids

  • Global Over the Counter (OTC) Drugs Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacy

Other

  • Global Over the Counter (OTC) Drugs Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global over the counter (OTC) drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Over the Counter (OTC) Drugs Market

4. Executive Summary

5. Voice of Customer

6. Global Over the Counter (OTC) Drugs Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Cough, Cold, and Flu, Analgesics, Dermatology Products, Vitamins, Mineral, and Supplements (VMS), Other)
    • 6.2.2. By Dosage Form (Tablets, Capsules, Powders, Ointments, Liquids)
    • 6.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Other)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Product Market Map

7. Asia-Pacific Over the Counter (OTC) Drugs Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Dosage Form
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Over the Counter (OTC) Drugs Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Dosage Form
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. India Over the Counter (OTC) Drugs Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Dosage Form
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Australia Over the Counter (OTC) Drugs Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Dosage Form
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. Japan Over the Counter (OTC) Drugs Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Dosage Form
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. South Korea Over the Counter (OTC) Drugs Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Dosage Form
        • 7.3.5.2.3. By Distribution Channel

8. Europe Over the Counter (OTC) Drugs Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Dosage Form
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Over the Counter (OTC) Drugs Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Dosage Form
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. Germany Over the Counter (OTC) Drugs Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Dosage Form
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. United Kingdom Over the Counter (OTC) Drugs Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Dosage Form
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. Italy Over the Counter (OTC) Drugs Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Dosage Form
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Spain Over the Counter (OTC) Drugs Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Dosage Form
        • 8.3.5.2.3. By Distribution Channel

9. North America Over the Counter (OTC) Drugs Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Dosage Form
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Over the Counter (OTC) Drugs Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Dosage Form
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Mexico Over the Counter (OTC) Drugs Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Dosage Form
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Canada Over the Counter (OTC) Drugs Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Dosage Form
        • 9.3.3.2.3. By Distribution Channel

10. South America Over the Counter (OTC) Drugs Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Dosage Form
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Over the Counter (OTC) Drugs Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Dosage Form
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Argentina Over the Counter (OTC) Drugs Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Dosage Form
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. Colombia Over the Counter (OTC) Drugs Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Dosage Form
        • 10.3.3.2.3. By Distribution Channel

11. Middle East and Africa Over the Counter (OTC) Drugs Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product
    • 11.2.2. By Dosage Form
    • 11.2.3. By Distribution Channel
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Over the Counter (OTC) Drugs Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product
        • 11.3.1.2.2. By Dosage Form
        • 11.3.1.2.3. By Distribution Channel
    • 11.3.2. Saudi Arabia Over the Counter (OTC) Drugs Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product
        • 11.3.2.2.2. By Dosage Form
        • 11.3.2.2.3. By Distribution Channel
    • 11.3.3. UAE Over the Counter (OTC) Drugs Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product
        • 11.3.3.2.2. By Dosage Form
        • 11.3.3.2.3. By Distribution Channel
    • 11.3.4. Kuwait Over the Counter (OTC) Drugs Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product
        • 11.3.4.2.2. By Dosage Form
        • 11.3.4.2.3. By Distribution Channel

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Competition Outlook
  • 14.2. Company Profiles
  • 14.3. Leading Players Profiled
    • 14.3.1. Johnson and Johnson
    • 14.3.2. GlaxoSmithKline PLC (GSK Consumer Healthcare)
    • 14.3.3. Perrigo Company PLC
    • 14.3.4. Reckitt Benckiser Group PLC
    • 14.3.5. Takeda Pharmaceutical Company Ltd
    • 14.3.6. Roche Holding AG
    • 14.3.7. The Procter & Gamble Company
    • 14.3.8. Sanofi S.A
    • 14.3.9. Gilead Sciences Inc.
    • 14.3.10. Bayer Healthcare AG
    • 14.3.11. AstraZeneca plc.
    • 14.3.12. Alacer Corp.
    • 14.3.13. Alcon Inc.

15. Strategic Recommendations

16. About Us & Disclaimer

Back to Top
전화 문의
F A Q